Zydus Healthcare Ltd (GERMANREM) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 500156 | NSE: GERMANREM | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Zydus Healthcare

Based on:

M-Cap below 100cr DeciZen not available

Zydus Healthcare stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.56
Market Cap:
390.2 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Zydus Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 1%4%3.6%7.2%6.5%10.1%16.3%14.9%17.3%21.5%-
Value Creation
Index
-0.9-0.7-0.7-0.5-0.5-0.30.20.10.20.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1632,8122,9713,1292,8673,1823,4723,6513,8774,0953,472
Sales YoY Gr.-1,629.5%5.7%5.3%-8.4%11%9.1%5.2%6.2%5.6%-
Adj EPS 541.7520.8416.7794.18551,048.22,825.93,325.93,890.74,866.2845.8
YoY Gr.--3.9%-20%90.6%7.7%22.6%169.6%17.7%17%25.1%-
BVPS (₹) 3,78020,087.120,897.219,855.316,607.417,638.720,862.223,437.324,949.328,514.810
Adj Net
Profit
2.610190.11721852276117198411,052698
Cash Flow from Ops. 45.95106377321,0109141,0751,1141,1161,198-
Debt/CF from Ops. 10.5000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 43.1%7.4%5.7%5.6%
Adj EPS 27.6%41.6%19.9%25.1%
BVPS25.2%11.4%11%14.3%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0.11.91.63.13.74.813.1151618.15.9
Op. Profit
Mgn %
58.425.625.229.528.4313331.431.936.90
Net Profit
Mgn %
1.63.635.56.57.117.619.721.725.720.1
Debt to
Equity
25.6000000000-
Working Cap
Days
6681061431651982282503044134890
Cash Conv.
Cycle
1471513715997560

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Zydus Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) 845.8 -
TTM Sales (₹ Cr.) 3,472 -
BVPS (₹.) 10 -
Reserves (₹ Cr.) - -
P/BV 47.32 -
PE 0.56 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) 194.45 / 1390.00
Market Cap (₹ Cr.) 390
Equity (₹ Cr.) 8.3
Face Value (₹) 10
Industry PE 39.4

Management X-Ray of Zydus Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Zydus Healthcare - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Zydus Healthcare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales162.602,812.102,971.403,1292,866.903,181.903,4723,651.203,899.504,094.60
Operating Expenses 67.702,092.402,222.902,207.602,052.602,194.602,326.902,5082,664.702,585.50
Manufacturing Costs8.30291.80191.60235.60337.30351.80402.30376.80403376
Material Costs15884.801,060.80705.20617.40738.20782.50814825.90641.30
Employee Cost 2.20437.70476.20515588.20622.40644.20736.20737.90796.60
Other Costs 42.20478.10494.30751.80509.70482.20497.90581697.90771.60
Operating Profit 94.90719.70748.50921.40814.30987.301,145.101,143.201,234.801,509.10
Operating Profit Margin (%) 58.4%25.6%25.2%29.4%28.4%31.0%33.0%31.3%31.7%36.9%
Other Income 0.102.9013.604174.8061.4079.60146.30243.80309.30
Interest 6.2031.902.302.201.905.300.600.600.600.40
Depreciation 68.20502.20553.30561.90566.60569.20574.90575.20572.60568.80
Exceptional Items 000000112.70000
Profit Before Tax 20.60188.50206.50398.30320.60474.20761.90713.70905.401,249.20
Tax 1887.70116.50226.70136.20247.4064.50-15.5053.70187.10
Profit After Tax 2.60100.8090171.60184.40226.80697.40729.20851.701,062.10
PAT Margin (%) 1.6%3.6%3.0%5.5%6.4%7.1%20.1%20.0%21.8%25.9%
Adjusted EPS (₹)520.0519.6414.8790.8849.81,045.23,213.83,360.43,924.94,894.5
Dividend Payout Ratio (%)365%289%259%145%2%0%0%23%60%27%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 18.905,133.405,771.205,315.104,610.304,834.104,527.105,085.905,4146,187.70
Share Capital 0.501,255.901,258.201,028.201,028.201,028.2021.7021.7021.7021.70
Reserves 18.403,877.504,5134,286.903,582.103,805.904,505.405,064.205,392.306,166
Minority Interest0000000000
Debt483.4020200000000
Long Term Debt3320200000000
Short Term Debt450.40000000000
Trade Payables84.60418.20465.50398.20400492.50536.70455.90463.20461.20
Others Liabilities 4,793.80705.10290207.50580.40820.90861.10871.50964.701,092.40
Total Liabilities 5,380.706,276.706,546.705,920.805,590.706,147.505,924.906,413.306,841.907,741.30

Fixed Assets

Gross Block4,798.105,684.905,803.205,925.805,962.906,027.606,054.806,076.506,115.406,142.60
Accumulated Depreciation69.205711,124.601,686.202,251.802,819.303,391.903,964.904,535.505,101.70
Net Fixed Assets 4,728.905,113.904,678.604,239.603,711.103,208.302,662.902,111.601,579.901,040.90
CWIP 0.7060.506118.703.405.100.801.1010.4035
Investments 0.901.80104.4092.80188.80365.50531.70469.60217.10402.50
Inventories134.30314.20374370.30375.50466.30531.20425.50380.70452
Trade Receivables137.70266.50301.50286.70178220.50253.20268.30297.60337.80
Cash Equivalents 23.6020.40432.6012.70130.10144.70398.6020.7024.80307
Others Assets 354.60499.40594.609001,003.801,737.101,546.503,116.504,331.405,166.10
Total Assets 5,380.706,276.706,546.705,920.805,590.706,147.505,924.906,413.306,841.907,741.30

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 45.90510.40636.80731.501,010.10914.101,074.501,114.301,116.401,197.80
PBT 20.60188.50206.50398.30320.60474.20761.90713.70905.401,249.20
Adjustment 74.30539.60552.60524.50525.30618.90440.20411.80334.60298.50
Changes in Working Capital -9.1-180.6-91.1-87.1249.2-101.443.2105.737.4-172.5
Tax Paid -39.90-37.10-31.20-104.20-85-77.60-170.80-116.90-161-177.40
Cash Flow From Investing Activity -56.80-904.20-112.40-424.80-186.50-811.50186.90-1,034.60-602-883.60
Capex -60.90-906.90-110-73.90-22.20-65.4090.90-26.80-61.10-45.80
Net Investments 4009.20-175.70-38.60-153.90368.20260.20-416.80
Others 0.102.70-2.40-360.1011.40-707.50249.90-1,376-801.10-421
Cash Flow From Financing Activity 18.30369.70-11.50-638.10-820.20-21.40-1,007.50-169-508.80-282.90
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0-130-6.900-13.200000
Interest Paid -2.70-37.10-2.30-1.80-0.90-4.900000
Dividend Paid -15.30-300.30-5.10-331.30-679.60-3.300-168.60-508-282.10
Others 36.30720.10-4.10-298.10-139.700-1,007.50-0.40-0.80-0.80
Net Cash Flow 7.40-24.10512.90-331.403.4081.20253.90-89.305.6031.30

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)15.95.152.133.884.666.116.6915.1716.2218.31
ROCE (%)1.034.043.637.26.4810.1416.2914.8617.2621.54
Asset Turnover Ratio0.060.50.470.50.50.540.580.60.590.56
PAT to CFO Conversion(x)17.655.067.084.265.484.031.541.531.311.13
Working Capital Days
Receivable Days294253534302325262628
Inventory Days287284243474852473837
Payable Days1,029104152224236221240223203263

Zydus Healthcare Ltd Stock News

Zydus Healthcare Ltd FAQs

The current trading price of Zydus Healthcare on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zydus Healthcare stood at ₹390.2.
The latest P/E ratio of Zydus Healthcare as of 31-Dec-1969 is 0.56.
The latest P/B ratio of Zydus Healthcare as of 31-Dec-1969 is 47.32.
The 52-week high of Zydus Healthcare is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zydus Healthcare is ₹3,472 ( Cr.) .

About Zydus Healthcare Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×